
Navamedic Investor Relations Material
Latest events

Q2 2025
Navamedic
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Navamedic
Access all reports
Navamedic ASA is a Norwegian pharmaceutical company focused on developing, producing, marketing, and distributing a range of healthcare products. Its portfolio includes both prescription and non-prescription pharmaceuticals, medical nutrition products, medical devices, and consumer health items such as food supplements and cosmetics. The company primarily serves hospitals, pharmacies, and patients across the Nordic countries, Benelux, and the Baltics, with additional presence in the UK and other European markets. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange.
Key slides for Navamedic


Q2 2025
Navamedic


M&A Announcement
Navamedic
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NAVA
Country
🇳🇴 Norway